Publisher
Springer Science and Business Media LLC
Reference66 articles.
1. Nishida T, Hiramatsu N, Mizuki M, Nagatomo I, Kida H, Tazumi K, et al. Managing hepatitis B virus carriers with systemic chemotherapy or biologic therapy in the outpatient clinic. Hepatol Res 2013;43(4):339–346.
https://doi.org/10.1111/j.1872-034X.2012.01073.x
(Epub 2012/08/14)
2. Wands JR, Chura CM, Roll FJ, Maddrey WC. Serial studies of hepatitis-associated antigen and antibody in patients receiving antitumor chemotherapy for myeloproliferative and lymphoproliferative disorders. Gastroenterology 1975;68(1):105–112 (Epub 1975/01/01)
3. Chazouilleres O, Mamish D, Kim M, Carey K, Ferrell L, Roberts JP, et al. “Occult” hepatitis B virus as source of infection in liver transplant recipients. Lancet 1994;343(8890):142–146 (Epub 1994/01/15)
4. Crespo J, Fabrega E, Casafont F, Rivero M, Heras G, de la Pena J, et al. Severe clinical course of de novo hepatitis B infection after liver transplantation. Liver Transpl Surg 1999;5(3):175–183.
https://doi.org/10.1002/lt.500050301
(Epub 1999/05/05)
5. Lau JY, Lai CL, Lin HJ, Lok AS, Liang RH, Wu PC, et al. Fatal reactivation of chronic hepatitis B virus infection following withdrawal of chemotherapy in lymphoma patients. Q J Med 1989;73(270):911–917 (Epub 1989/10/01)
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献